Depomed Rallies for Another Round with Serada
After receiving guidance from U.S. regulators, pharmaceutical company Depomed has announced a late-stage trial of its drug candidate for menopausal hot flashes.
After receiving guidance from U.S. regulators, pharmaceutical company Depomed has announced a late-stage trial of its drug candidate for menopausal hot flashes.
Investment website The Motley Fool has published a list of five stocks approaching greatness–and four of them are within the life sciences industry.
Copyright © 2024 | WordPress Theme by MH Themes